Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Interventional × iron isomaltoside 1000 × Clear all

Phase

Phase 3 3 Phase 4 2 Phase 2 2 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Non-hematological Malignancies 1

Interventions

Cyclophosphamide 543 pembrolizumab 425 Paclitaxel 386 Gemcitabine 370 Cisplatin 368 Carboplatin 363 Radiotherapy 326 fludarabine 311 Nivolumab 291 Docetaxel 239 Bevacizumab 237 Irinotecan 210 Magnetic Resonance Spectroscopy 207 Dexamethasone 194 Specimen Handling 192 Fluorouracil 191 Capecitabine 186 Cytarabine 176 Rituximab 175 fludarabine phosphate 170 Oxaliplatin 168 Biopsy 168 Temozolomide 167 Ipilimumab 163 Etoposide 157 Lenalidomide 155 Doxorubicin 147 Cetuximab 147 Leucovorin 144 Bortezomib 144

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01213979 2013-06-27

PK-CIA-04

Pharmacosmos A/S

Phase 1 Completed

Non-hematological Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡